[ Price : $8.95]
FDA medical reviewers question the demonstration of efficacy in an Otsuka NDA for a combination of Rexulti and Zoloft to treat PTS...[ Price : $8.95]
FDA lifts a partial clinical hold against Kezar Life Sciences and its completed PORTOLA Phase 2a clinical trial evaluating zetomip...[ Price : $8.95]
HHS notifies over 3,000 FDA employees that their employment has been officially terminated effective 7/14.[ Price : $8.95]
FDA warns South Koreas Daewoo Pharmaceutical Co. about CGMP violations in its production of finished drugs.[ Price : $8.95]
A Benefits Pensions Monitor report says FDA drug inspection backlogs can hurt Canada since FDA has been performing 70% of Canadas ...[ Price : $8.95]
FDA reviewers plan to ask an advisory committee this week about its concerns with ocular toxicity seen in trial data submitted by ...[ Price : $8.95]
FDA warns Dr. Mark Savant and his San Francisco Research Institute about bioresearch monitoring violations in his conduct of a cli...[ Price : $8.95]
FDA approves a Biocon Biologics BLA for its rapid-acting interchangeable biosimilar insulin product Kirsty (insulin aspart-xjhz).